GSK ' s HIV Prevention Drug Recommended for EU Approval GSK ' s HIV Prevention Drug Recommended for EU Approval

GSK has said its HIV-focused unit ViiV Healthcare ' s cabotegravir long-acting injectable and tablets had received a recommendation for marketing authorization from the EMA.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news